On February 29, 2024, Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the symbol INBS, reported entering into two separate agreements to enhance its advisory and investor relations services. The first agreement, with C2C Advisors Inc., involves a 6-month term where C2C will provide advisory services for a monthly fee of $25,000 and a one-time grant of 37,500 restricted shares of common stock. The second agreement, with ClearThink Capital LLC, includes an initial grant of 5,260 restricted shares and a monthly fee of $5,000 plus $4,000 worth of restricted common stock, calculated quarterly. Both agreements are effective as of February 29, 2024, with the ClearThink Agreement allowing for termination by either party after three months. The shares from both agreements will be issued under an exemption from registration according to Section 4(a)(2) of the Securities Act of 1933.

On February 29, 2024, Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the symbol INBS, reported entering into two separate agreements to enhance its advisory and investor relations services. The first agreement, with C2C Advisors Inc., involves a 6-month term where C2C will provide advisory services for a monthly fee of $25,000 and a one-time grant of 37,500 restricted shares of common stock. The second agreement, with ClearThink Capital LLC, includes an initial grant of 5,260 restricted shares and a monthly fee of $5,000 plus $4,000 worth of restricted common stock, calculated quarterly. Both agreements are effective as of February 29, 2024, with the ClearThink Agreement allowing for termination by either party after three months. The shares from both agreements will be issued under an exemption from registration according to Section 4(a)(2) of the Securities Act of 1933.